Ubs Asset Management Americas Inc Amphastar Pharmaceuticals, Inc. Transaction History
Ubs Asset Management Americas Inc
- $379 Billion
- Q1 2025
A detailed history of Ubs Asset Management Americas Inc transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 79,089 shares of AMPH stock, worth $2.06 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
79,089
Previous 83,231
4.98%
Holding current value
$2.06 Million
Previous $3.09 Million
25.83%
% of portfolio
0.0%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding AMPH
# of Institutions
257Shares Held
33.6MCall Options Held
20.8KPut Options Held
11.6K-
Black Rock Inc. New York, NY5.94MShares$155 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.42MShares$63 Million0.0% of portfolio
-
Td Asset Management Inc2.21MShares$57.5 Million0.06% of portfolio
-
State Street Corp Boston, MA1.6MShares$41.7 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.36MShares$35.3 Million0.01% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.27B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...